333 related articles for article (PubMed ID: 10207051)
1. MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
[TBL] [Abstract][Full Text] [Related]
2. A possible role of p73 on the modulation of p53 level through MDM2.
Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
[TBL] [Abstract][Full Text] [Related]
3. MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
5. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
[TBL] [Abstract][Full Text] [Related]
6. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
7. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.
Zeng X; Li X; Miller A; Yuan Z; Yuan W; Kwok RP; Goodman R; Lu H
Mol Cell Biol; 2000 Feb; 20(4):1299-310. PubMed ID: 10648616
[TBL] [Abstract][Full Text] [Related]
9. p73 transcriptional activity increases upon cooperation between its spliced forms.
Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
[TBL] [Abstract][Full Text] [Related]
11. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
12. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 binds p73 alpha without targeting degradation.
Bálint E; Bates S; Vousden KH
Oncogene; 1999 Jul; 18(27):3923-9. PubMed ID: 10435614
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein.
Dobbelstein M; Wienzek S; König C; Roth J
Oncogene; 1999 Mar; 18(12):2101-6. PubMed ID: 10321734
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
Zhu Q; Yao J; Wani G; Wani MA; Wani AA
J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
[TBL] [Abstract][Full Text] [Related]
17. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
18. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.
Steegenga WT; Shvarts A; Riteco N; Bos JL; Jochemsen AG
Mol Cell Biol; 1999 May; 19(5):3885-94. PubMed ID: 10207112
[TBL] [Abstract][Full Text] [Related]
19. Targeting of p53 and its homolog p73 by protoporphyrin IX.
Sznarkowska A; Maleńczyk K; Kadziński L; Bielawski KP; Banecki B; Zawacka-Pankau J
FEBS Lett; 2011 Jan; 585(1):255-60. PubMed ID: 21146529
[TBL] [Abstract][Full Text] [Related]
20. Functional interplay between MDM2, p63/p73 and mutant p53.
Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
